Mutation burden as a potential prognostic marker of melanoma progression and survival.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: NYU Langone Health, New York University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891401570
